Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Go back to Taysha Gene Therapies Reports Second Quarter 2026 Financial Results and Provides Corporate Update| (NASDAQ: TSHA) | Delayed: 5.34 -0.14 (2.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.48 | 52 Week High | $ | |||
| Open | $5.40 | 52 Week Low | $ | |||
| Day High | $5.49 | P/E | N/A | |||
| Day Low | $5.29 | EPS | $ | |||
| Volume | 1,810,761 | |||||
| (NASDAQ: TSHA) | Delayed: 5.34 -0.14 (2.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.48 | 52 Week High | $ | |||
| Open | $5.40 | 52 Week Low | $ | |||
| Day High | $5.49 | P/E | N/A | |||
| Day Low | $5.29 | EPS | $ | |||
| Volume | 1,810,761 | |||||

